News & Events

GRANT: Skolarus receives R01 to de-implement low value castration in men with prostate cancer

February 16, 2018   |   Rebekah Jacob

Dr. Ted Skolarus (MT-DIRC fellow, 2014 cohort) recently received word from the National Cancer Institute of funding for his R01 entitled De-implementation of low value castration for men with prostate cancer.

According to Dr. Skolarus, the study will “transform how and why low value castration is practiced, and advance the science behind stopping low value, even harmful, cancer treatments.”

Find out more about Dr. Skolarus and his work here.